For each trial, check who or what was studied, which preparation was used and what the findings support before comparing it with personal reports about individual experiences or seller listings that describe a product but don’t establish that it works.
Regulatory context
Regulatory context; not efficacy evidence
No matched controlled clinical study of this exact preparation was verified in this source audit.
Reported findings. Background context only. Matched evidence for the exact marketed formulation is not established by this reference.
Nonresponse. Nonresponse frequency not established in this excerpt.
Harms. Unknown in reviewed excerpt; absence of mention is not safety evidence.
Limits. Related-compound evidence is contextual only. Commercial names, modifications and routes do not establish clinical equivalence.
Preparation: Source preparation; commercial equivalence unverified. Route: Unknown in reviewed excerpt; do not infer.
Read original source ↗Editorial review 2026-10-09. Clinician review pending.
Human report
Public MK777 sleep experience, preparation and co-interventions
Two public comments with deleted authorship; number of distinct reporters unverified. Possible duplicate conservatively grouped.
Reported findings. June2 reports improved deep/REM sleep through wearable observation without supplied readings, less appetite stimulation and less bloating/water retention than prior MK677 experience. June13 separately reports improved sleep and perceived muscle growth, less hunger and no belly bloating; identity relationship to June2 unresolved.
Nonresponse. No defined formal nonresponse endpoint; body composition and hormone measurements unverified.
Harms. Comprehensive adverse-event assessment not supplied; absence of described bloating is not established general safety.
Limits. June2 discloses concurrent RAD140, SLU-PP332 and resistance training; June13 co-interventions unspecified and do not inherit June2 details. Deleted authorship prevents verifying same-person identity; grouping avoids counting two confirmed independent successes. Marketed MK777/acetamoren chemistry, purity and catalog-stock equivalence unverified; no causal proof or established safety.
Preparation: June2 comment names a polycell sublingual preparation marketed as MK777. June13 comment preparation unspecified. Route: June2 explicitly sublingual; June13 route unspecified.
Read original source ↗Editorial review 2026-10-10. Clinician review pending.
Human report
Public MK777 benefits followed by dizziness and blackout
One public firsthand account; clinical event unverified.
Reported findings. Initially reports nonspecific better results and reduced bloating compared with prior MK677 experience.
Nonresponse. Discontinued after reported adverse experience; no defined efficacy endpoint.
Harms. Reported severe dizziness, blackout with awakening on floor, and another dizzy episode after omitting use. No verified diagnosis or causal allocation.
Limits. Looking for melatonin before the episode does not establish ingestion before it; current concurrent exposures incompletely documented. Prior SARM exposure disclosed. Reporter insulin explanation is speculation, not a demonstrated mechanism. Later source-refusal and discussion replies do not describe another blackout or independent adverse event. Marketed MK777/acetamoren chemistry, purity and catalog-stock equivalence unverified; no causal proof or established safety.
Preparation: Named MK777; preparation and purity unspecified. Route: Not stated in original report.
Read original source ↗Editorial review 2026-10-10. Clinician review pending.
Human report
Public MK777 PEG400 energy, sleep and thirst experience
One public account repeated by same source author; counted once.
Reported findings. Reported marked energy and perceived anabolic effects, with less bloating than prior MK677 experience.
Nonresponse. No verified hormone, muscle-growth or formal efficacy endpoint.
Harms. Insomnia, thirst and intermittent fatigue/crashing reported.
Limits. Recent dental procedure, antibiotics and bleeding confound the sleep account. Unverified glucose reading without supplied value cannot establish absence of insulin resistance or metabolic risk. Same-author comment nhsjvku repeats this body; it is not another independent experience. Vendor endorsement and unsupported potency, chemistry and hormone explanations are not adopted as facts. Marketed MK777/acetamoren chemistry, purity and catalog-stock equivalence unverified; no causal proof or established safety.
Preparation: Vendor-identified PEG400 solution marketed as MK777; chemistry unverified. Route: Route not explicit; solution vehicle does not establish oral or sublingual administration.
Read original source ↗Editorial review 2026-10-10. Clinician review pending.